Alcon brings Balance eye drops to Latin America
This article was originally published in The Tan Sheet
By the end of 2010, Alcon plans to distribute in Latin America Systane Balance Lubricant Eye Drops for consumers who have dysfunctional meibomian glands, a condition commonly linked to dry eye syndrome. The Swiss firm said Oct. 11 Systane Balance contains hydroxypropyl-guar - derived from the Guar galactomannan water-soluble polysaccharide - borate, sorbitol, propylene glycol and Alcon's LipiTech System, an emulsion technology of mineral oil and an anionic phospholipid. Alcon designed the product to restore the lipid layer and the natural tear film to allow for relief of dry eye symptoms. Tear film instability can occur when meibomian glands in eyelids do not secrete adequate amounts of lipid to seal the aqueous tears and prevent evaporation. Alcon launched the product in the U.S. in July. A 10-mL bottle of Systane Balance is available online for $12.99 and a two-bottle pack for $19.99
You may also be interested in...
More than half a dozen generic rivaroxaban brands are now available in India, putting the heat on Bayer’s blockbuster anticoagulant Xarelto in the price-sensitive market. Many rival generics are priced over 50% lower than the innovator product.
In this week’s podcast, Medtech Insight's managing editor Marion Webb and deputy editor Reed Miller discuss highlights from the recent J.P. Morgan Healthcare and North American Neuromodulation Society (NANS) virtual meetings. London, UK-based reporter Barnaby Pickering profiles start-up CorWave SA, which developed a left ventricular assist device for treating end-stage heart failure.
Tom McLain tells how the new MCIT policy from the US Medicare agency – and winning support from Congress – will guarantee Medicare coverage for his company’s product, an artificial intelligence-enabled in vitro diagnostic platform.